Pfizer 2018 Annual Review: Patients at Our Center

Pfizer 2018 Annual Review: Patients at Our Center

Pfizer’s 2018 integrated annual review provides an in-depth look at the company’s financial, social and environmental performance throughout 2018, with a specific focus on the “Patients at Our Center” who drive every aspect of the company’s work. The report shows how patients are the driving force behind everything from patient access and philanthropy, to research and development, to manufacturing. View the full report at www.Pfizer.com/annual and follow along on this page for highlights from the report.

Content from this campaign

Pfizer’s Three Virtues Initiative Strives to Transform African American Health and Wellness
African Americans are disproportionately affected by many diseases and Pfizer is committed to improving health among this segment of the population through science, partnerships, insights and expertise. Three Virtues is our integrated, enterprise-wide initiative aiming to: Achieve a measurable reduction in health disparities, increase clinical trial participation and improve...
Oct 10, 2019 11:40 AM ET
Pfizer’s Vaccine Research & Development Program Applies Transformative Science to Help Protect People of All Ages
At Pfizer, we discover and develop novel vaccines that help protect people around the world from deadly viruses and bacteria. In 2018, we focused on...
Aug 6, 2019 10:00 AM ET
Making Strides in the Responsible Manufacturing of Antibiotics
Pfizer is committed to ensuring that the manufacturing, use and disposal of our products, including antibiotics, does not adversely affect human health or the environment. Core to this commitment is taking action to assess and reduce, as needed, the risk of antibiotics in wastewater from Pfizer and supplier manufacturing facilities Responsible antibiotic manufacturing practices are part...
Jul 1, 2019 12:25 PM ET
Pfizer Utilizes Framework to Enable Quicker, More Effective Response to Major Societal Issues
We live in challenging, often contentious times, with political, cultural and environmental issues constantly brewing. Companies across industries face the daunting task of appropriately responding to issues and news on a regular basis, and to help guide our responses at Pfizer, we developed our Social Framework – a way to determine if, when, how and why we will address a societal issue....
May 13, 2019 11:00 AM ET
Pfizer Reaffirms Commitment to Delivering Essential Therapies Through Manufacturing Investment
We are experiencing an exciting new era in drug discovery and development with scientific advances that could result in future breakthroughs. To make this promise a reality, Pfizer is dedicated to investing in manufacturing capabilities to keep pace with science today, and to plan for what’s coming next. In 2018, we took an important step forward with the announcement of a $465 million...
Apr 15, 2019 11:00 AM ET

Pages